Clinical trial
A Dose-escalation Study to Investigate Safety and Toleration of OZ439
A randomised, placebo-controlled, dose-escalation study to investigate safety and toleration of OZ439 OD for 3 days to healthy male and female volunteers. The study aims:
To determine the safety and tolerability of ascending doses of OZ439 OD for three days.
To assess pharmacokinetic parameters of ascending doses of OZ439 given OD.
To identify the maximum tolerated dose of OZ439 administered.
| Category | Value |
|---|---|
| Study start date | 2012-10-22 |